Us Professionals Recommend A Moderna’s Vaccine Boosting

On October 14, the American Food and Pharmaceutical Advisory Council (FDA) was recommended to increase the Covid-19 Covid-19 vaccine vaccination for some high-risk groups in the US. . Last month, the Council also launched a similar recommendation for the approved Pfizer and FDA vaccines. In: 00/2: 50 Southern region of Vaccine prevented Covid-19 for people in Seattle, Washington, USA. Artwork: AFP / VNA, FDA Expert Council decided to enhance Moderna's vaccine injection for groups: people over 65 years of age; People in the age of 18-64 are at risk of severe illness when infected with viruses; and people working in areas are at high risk of infection such as supermarket staff, medical staff, employees in the homeless center

. People in the above objects will inject 6 months After completing Moderna's 2 vaccine nose injection. The third tip dose is 50 micrograms / nose, only half of the first two nose. This decision is given after the 1-day discussion of the FDA Advisory Council Moderna Pharmaceutist has submitted an application for FDA to approve its Covid-19 Covid-19 vaccine for high-risk groups, in the context of Delta variant spread in the US. Browse Injections Increasing Vaccine Vaccine Covid-19 of Pfizer for people over 65 years of age, people are at high risk of severe illness and high risk of SARS-COV-2 virus infections, the FDA specialist Meeting on October 15 considers the enhancement of Johnson's vaccine

. Dịch vụ: Thiết kế website, quảng cáo google, đăng ký website bộ công thương uy tín